Login

Consolidated Balance Sheets

In USD, except per-share amounts
Q4 FY2024
As of Sep 30, 2024
Q3 FY2024
As of Jun 30, 2024
Q2 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Sep 30, 2023
Q3 FY2023
As of Jun 30, 2023
Q2 FY2023
As of Mar 31, 2023
Q1 FY2023
As of Dec 31, 2022
Q4 FY2022
As of Sep 30, 2022
Q3 FY2022
As of Jun 30, 2022
Q2 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Sep 30, 2020
Q3 FY2020
As of Jun 30, 2020
Q2 FY2020
As of Mar 31, 2020
Q1 FY2020
As of Dec 31, 2019
Q3 FY2019
As of Jun 30, 2019
Q2 FY2019
As of Mar 31, 2019
Q1 FY2019
As of Dec 31, 2018
Q4 FY2018
As of Sep 30, 2018
Cash and cash equivalents
Accounts receivable
Unbilled receivables
Prepaid expenses and other current assets
Income tax receivable
Total Current Assets
Right-of-use asset, net
Property and equipment, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses
Accounts payable and accrued expenses, related party
Unearned revenues
Lease obligation, current
Total Current Liabilities
Lease obligation, net of current portion
Deferred tax liabilities
Total Liabilities
Stockholders' Equity
Preferred stock: 1,000,000 shares authorized; $0.001 par value; no shares issued and outstanding
Common stock: 125,000,000 shares authorized; $0.001 par value; 34,505,520 shares issued and outstanding
Common stock to be issued; 0 and 135,000 shares as of September 30, 2022 and 2021, respectively
Additional paid in capital
Retained earnings
Total Stockholders' Equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support